Concepts (269)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Critical Care | 20 | 2022 | 659 | 4.390 |
Why?
|
| Heart Defects, Congenital | 26 | 2022 | 1840 | 3.490 |
Why?
|
| Cardiopulmonary Bypass | 14 | 2021 | 360 | 3.240 |
Why?
|
| Cardiac Surgical Procedures | 17 | 2024 | 1121 | 2.360 |
Why?
|
| Pediatrics | 12 | 2022 | 1205 | 2.220 |
Why?
|
| Hemodynamics | 14 | 2023 | 800 | 2.070 |
Why?
|
| Critical Illness | 11 | 2023 | 600 | 2.070 |
Why?
|
| Monitoring, Physiologic | 11 | 2022 | 370 | 1.720 |
Why?
|
| Oxygen | 8 | 2021 | 544 | 1.620 |
Why?
|
| Intensive Care Units, Pediatric | 9 | 2021 | 472 | 1.490 |
Why?
|
| Shock, Cardiogenic | 2 | 2023 | 170 | 1.470 |
Why?
|
| Cardiology | 4 | 2017 | 472 | 1.460 |
Why?
|
| Oximetry | 7 | 2021 | 174 | 1.330 |
Why?
|
| Heart Failure | 8 | 2016 | 2165 | 1.320 |
Why?
|
| Spectroscopy, Near-Infrared | 4 | 2021 | 148 | 1.300 |
Why?
|
| Cardiovascular System | 2 | 2023 | 99 | 1.210 |
Why?
|
| Capnography | 2 | 2020 | 13 | 1.210 |
Why?
|
| Heart Diseases | 4 | 2019 | 485 | 1.170 |
Why?
|
| Sepsis | 2 | 2023 | 486 | 1.160 |
Why?
|
| Child | 46 | 2022 | 25112 | 0.970 |
Why?
|
| Nitric Oxide | 5 | 2019 | 462 | 0.960 |
Why?
|
| Natriuretic Peptide, Brain | 3 | 2017 | 276 | 0.910 |
Why?
|
| Cardiac Output | 7 | 2022 | 159 | 0.890 |
Why?
|
| Physicians | 3 | 2022 | 617 | 0.860 |
Why?
|
| Humans | 84 | 2024 | 126129 | 0.860 |
Why?
|
| Arginine Vasopressin | 1 | 2023 | 25 | 0.830 |
Why?
|
| Heart | 4 | 2023 | 645 | 0.820 |
Why?
|
| Blood Pressure | 6 | 2022 | 1302 | 0.770 |
Why?
|
| Extracorporeal Membrane Oxygenation | 6 | 2014 | 667 | 0.750 |
Why?
|
| Hypertension, Pulmonary | 5 | 2019 | 442 | 0.740 |
Why?
|
| Cerebrovascular Circulation | 3 | 2021 | 449 | 0.730 |
Why?
|
| Certification | 2 | 2019 | 68 | 0.720 |
Why?
|
| Tetralogy of Fallot | 3 | 2012 | 173 | 0.710 |
Why?
|
| Cardiomyopathy, Hypertrophic | 2 | 2021 | 154 | 0.710 |
Why?
|
| Postoperative Complications | 8 | 2020 | 2981 | 0.710 |
Why?
|
| Inflammation | 2 | 2020 | 1433 | 0.700 |
Why?
|
| Lung | 2 | 2020 | 1523 | 0.700 |
Why?
|
| Fontan Procedure | 1 | 2023 | 187 | 0.690 |
Why?
|
| Acute Kidney Injury | 3 | 2017 | 601 | 0.680 |
Why?
|
| Heart-Assist Devices | 3 | 2022 | 1029 | 0.680 |
Why?
|
| Natriuretic Agents | 2 | 2017 | 22 | 0.660 |
Why?
|
| Infant, Newborn | 17 | 2022 | 8381 | 0.640 |
Why?
|
| Infant | 24 | 2020 | 12803 | 0.610 |
Why?
|
| Triiodothyronine | 1 | 2019 | 54 | 0.600 |
Why?
|
| Internationality | 1 | 2019 | 129 | 0.590 |
Why?
|
| Education, Medical, Graduate | 2 | 2022 | 505 | 0.580 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 332 | 0.570 |
Why?
|
| Hypothyroidism | 1 | 2019 | 78 | 0.570 |
Why?
|
| Postoperative Care | 5 | 2020 | 303 | 0.570 |
Why?
|
| Respiratory Tract Diseases | 2 | 2016 | 79 | 0.560 |
Why?
|
| Curriculum | 2 | 2022 | 754 | 0.560 |
Why?
|
| Hospital Mortality | 5 | 2021 | 969 | 0.550 |
Why?
|
| Severity of Illness Index | 3 | 2021 | 2926 | 0.530 |
Why?
|
| Vasopressins | 3 | 2021 | 44 | 0.520 |
Why?
|
| Carbon Dioxide | 2 | 2020 | 270 | 0.520 |
Why?
|
| Hormone Replacement Therapy | 1 | 2019 | 209 | 0.500 |
Why?
|
| Immunomodulation | 1 | 2016 | 76 | 0.490 |
Why?
|
| Respiratory System | 1 | 2016 | 94 | 0.480 |
Why?
|
| Reperfusion Injury | 1 | 2016 | 108 | 0.470 |
Why?
|
| Clinical Competence | 2 | 2019 | 983 | 0.470 |
Why?
|
| Societies, Medical | 5 | 2015 | 724 | 0.470 |
Why?
|
| Shock | 1 | 2016 | 96 | 0.460 |
Why?
|
| Immune System Diseases | 1 | 2015 | 50 | 0.460 |
Why?
|
| Child, Preschool | 18 | 2020 | 14375 | 0.450 |
Why?
|
| Congresses as Topic | 1 | 2015 | 175 | 0.430 |
Why?
|
| Child Abuse | 1 | 2017 | 198 | 0.430 |
Why?
|
| Education, Medical | 1 | 2017 | 276 | 0.420 |
Why?
|
| Shock, Septic | 1 | 2015 | 147 | 0.410 |
Why?
|
| Intra-Aortic Balloon Pumping | 1 | 2013 | 42 | 0.410 |
Why?
|
| Fellowships and Scholarships | 1 | 2016 | 310 | 0.400 |
Why?
|
| Ventilator Weaning | 2 | 2010 | 30 | 0.400 |
Why?
|
| Cardiovascular Diseases | 3 | 2016 | 2005 | 0.390 |
Why?
|
| Oxygen Consumption | 2 | 2011 | 298 | 0.390 |
Why?
|
| Vascular Resistance | 2 | 2020 | 185 | 0.390 |
Why?
|
| Vancomycin | 1 | 2014 | 224 | 0.380 |
Why?
|
| Regional Blood Flow | 1 | 2012 | 197 | 0.370 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 2011 | 16 | 0.360 |
Why?
|
| Length of Stay | 6 | 2021 | 1318 | 0.360 |
Why?
|
| Airway Extubation | 1 | 2012 | 70 | 0.350 |
Why?
|
| Intensive Care Units | 6 | 2020 | 480 | 0.330 |
Why?
|
| Cardiac Output, Low | 1 | 2010 | 61 | 0.330 |
Why?
|
| Positive-Pressure Respiration | 1 | 2010 | 82 | 0.330 |
Why?
|
| Interdisciplinary Communication | 1 | 2011 | 130 | 0.320 |
Why?
|
| Pituitary-Adrenal System | 1 | 2010 | 38 | 0.320 |
Why?
|
| Brain | 2 | 2012 | 3031 | 0.310 |
Why?
|
| Hypothalamo-Hypophyseal System | 1 | 2010 | 63 | 0.310 |
Why?
|
| Adrenal Insufficiency | 1 | 2010 | 29 | 0.310 |
Why?
|
| Treatment Outcome | 12 | 2024 | 12393 | 0.310 |
Why?
|
| Retrospective Studies | 15 | 2022 | 16831 | 0.310 |
Why?
|
| Ventricular Dysfunction, Right | 1 | 2010 | 76 | 0.300 |
Why?
|
| Coronary Care Units | 4 | 2020 | 28 | 0.300 |
Why?
|
| Evidence-Based Medicine | 2 | 2016 | 604 | 0.300 |
Why?
|
| Diuretics | 3 | 2019 | 137 | 0.290 |
Why?
|
| Postoperative Period | 4 | 2019 | 324 | 0.280 |
Why?
|
| Respiration, Artificial | 6 | 2019 | 485 | 0.280 |
Why?
|
| Steroids | 1 | 2009 | 156 | 0.280 |
Why?
|
| Infusions, Intravenous | 3 | 2020 | 523 | 0.280 |
Why?
|
| Peritoneal Dialysis | 2 | 2020 | 127 | 0.270 |
Why?
|
| Arteries | 2 | 2019 | 196 | 0.260 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2020 | 1179 | 0.250 |
Why?
|
| Fluid Therapy | 2 | 2022 | 145 | 0.250 |
Why?
|
| Hospitalization | 5 | 2021 | 1811 | 0.250 |
Why?
|
| Myocardial Reperfusion Injury | 2 | 2021 | 124 | 0.250 |
Why?
|
| Dexamethasone | 3 | 2005 | 263 | 0.240 |
Why?
|
| Anti-Inflammatory Agents | 4 | 2024 | 295 | 0.230 |
Why?
|
| Administration, Inhalation | 3 | 2019 | 184 | 0.230 |
Why?
|
| Prospective Studies | 7 | 2020 | 6178 | 0.230 |
Why?
|
| Respiration | 3 | 2016 | 119 | 0.230 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2009 | 330 | 0.230 |
Why?
|
| Male | 22 | 2020 | 62225 | 0.220 |
Why?
|
| Creatinine | 2 | 2017 | 360 | 0.210 |
Why?
|
| Acute Disease | 3 | 2016 | 1039 | 0.210 |
Why?
|
| Cause of Death | 2 | 2019 | 469 | 0.210 |
Why?
|
| Heart Rate | 3 | 2020 | 564 | 0.210 |
Why?
|
| Female | 22 | 2020 | 68037 | 0.210 |
Why?
|
| Mediastinum | 1 | 2023 | 47 | 0.200 |
Why?
|
| Time Factors | 6 | 2019 | 6030 | 0.200 |
Why?
|
| Hemodynamic Monitoring | 1 | 2022 | 16 | 0.190 |
Why?
|
| Cooperative Behavior | 2 | 2016 | 220 | 0.190 |
Why?
|
| Water | 1 | 2023 | 189 | 0.190 |
Why?
|
| Anti-Bacterial Agents | 1 | 2014 | 2509 | 0.190 |
Why?
|
| Vena Cava, Superior | 1 | 2021 | 57 | 0.170 |
Why?
|
| Case-Control Studies | 3 | 2019 | 3307 | 0.170 |
Why?
|
| Biological Transport | 2 | 2011 | 328 | 0.170 |
Why?
|
| Age Factors | 2 | 2019 | 2766 | 0.160 |
Why?
|
| United States | 6 | 2022 | 11187 | 0.160 |
Why?
|
| Nicardipine | 1 | 2020 | 13 | 0.160 |
Why?
|
| Tidal Volume | 1 | 2020 | 41 | 0.160 |
Why?
|
| Nitroprusside | 1 | 2020 | 36 | 0.160 |
Why?
|
| Sodium Bicarbonate | 1 | 2020 | 55 | 0.160 |
Why?
|
| Risk Assessment | 5 | 2021 | 3422 | 0.160 |
Why?
|
| Vasoconstrictor Agents | 1 | 2020 | 132 | 0.160 |
Why?
|
| Hypotension | 1 | 2021 | 177 | 0.160 |
Why?
|
| Cardiomyopathies | 2 | 2020 | 492 | 0.160 |
Why?
|
| Heart Septal Defects | 1 | 2019 | 36 | 0.150 |
Why?
|
| Noonan Syndrome | 1 | 2019 | 31 | 0.150 |
Why?
|
| Acidosis | 1 | 2020 | 100 | 0.150 |
Why?
|
| Arginine | 1 | 2021 | 335 | 0.150 |
Why?
|
| Bronchodilator Agents | 1 | 2019 | 147 | 0.140 |
Why?
|
| Heart Valve Diseases | 1 | 2019 | 166 | 0.140 |
Why?
|
| Respiratory Insufficiency | 2 | 2012 | 239 | 0.140 |
Why?
|
| Recovery of Function | 1 | 2019 | 422 | 0.130 |
Why?
|
| Oliguria | 1 | 2017 | 20 | 0.130 |
Why?
|
| Water-Electrolyte Balance | 1 | 2017 | 81 | 0.130 |
Why?
|
| Chlorothiazide | 1 | 2016 | 11 | 0.130 |
Why?
|
| Nephrons | 1 | 2016 | 17 | 0.130 |
Why?
|
| Diuresis | 1 | 2016 | 45 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2017 | 1598 | 0.130 |
Why?
|
| Nurses | 1 | 2017 | 77 | 0.130 |
Why?
|
| Veins | 1 | 2017 | 99 | 0.130 |
Why?
|
| Adolescent | 6 | 2021 | 19986 | 0.120 |
Why?
|
| Reoperation | 1 | 2019 | 791 | 0.120 |
Why?
|
| Risk Factors | 4 | 2020 | 10374 | 0.120 |
Why?
|
| Equipment and Supplies, Hospital | 1 | 2015 | 10 | 0.120 |
Why?
|
| Ventricular Pressure | 1 | 2016 | 36 | 0.120 |
Why?
|
| Specialization | 1 | 2016 | 74 | 0.120 |
Why?
|
| Alprostadil | 1 | 2015 | 22 | 0.120 |
Why?
|
| Inpatients | 1 | 2020 | 538 | 0.120 |
Why?
|
| Educational Measurement | 1 | 2017 | 273 | 0.120 |
Why?
|
| Survival Analysis | 3 | 2019 | 1475 | 0.120 |
Why?
|
| Drug Administration Schedule | 1 | 2017 | 735 | 0.120 |
Why?
|
| Weight Gain | 1 | 2017 | 376 | 0.110 |
Why?
|
| Heart Ventricles | 1 | 2019 | 748 | 0.110 |
Why?
|
| Angiotensin Receptor Antagonists | 1 | 2016 | 124 | 0.110 |
Why?
|
| Premedication | 2 | 2005 | 39 | 0.110 |
Why?
|
| Multivariate Analysis | 2 | 2015 | 1349 | 0.110 |
Why?
|
| Vasodilator Agents | 1 | 2015 | 190 | 0.110 |
Why?
|
| Follow-Up Studies | 3 | 2020 | 5107 | 0.110 |
Why?
|
| Single-Blind Method | 1 | 2014 | 231 | 0.110 |
Why?
|
| Cardiotonic Agents | 2 | 2014 | 132 | 0.110 |
Why?
|
| Pregnancy Complications | 2 | 2017 | 537 | 0.100 |
Why?
|
| Publications | 1 | 2013 | 35 | 0.100 |
Why?
|
| Emergency Service, Hospital | 1 | 2020 | 1019 | 0.100 |
Why?
|
| Chi-Square Distribution | 1 | 2014 | 541 | 0.100 |
Why?
|
| Databases, Factual | 3 | 2020 | 1171 | 0.100 |
Why?
|
| Global Health | 1 | 2017 | 605 | 0.100 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2014 | 210 | 0.100 |
Why?
|
| Endothelium-Dependent Relaxing Factors | 1 | 2012 | 5 | 0.090 |
Why?
|
| Fibrinolytic Agents | 1 | 2014 | 195 | 0.090 |
Why?
|
| Thrombolytic Therapy | 1 | 2014 | 203 | 0.090 |
Why?
|
| Logistic Models | 2 | 2014 | 1739 | 0.090 |
Why?
|
| Animals | 4 | 2024 | 33226 | 0.090 |
Why?
|
| Patient Care Team | 1 | 2016 | 547 | 0.090 |
Why?
|
| Lung Diseases | 1 | 2016 | 392 | 0.090 |
Why?
|
| Pulmonary Embolism | 1 | 2014 | 160 | 0.090 |
Why?
|
| Texas | 3 | 2015 | 3536 | 0.090 |
Why?
|
| Hypertension | 1 | 2020 | 1281 | 0.090 |
Why?
|
| Chronic Disease | 1 | 2016 | 1179 | 0.090 |
Why?
|
| Quality Control | 1 | 2011 | 116 | 0.090 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2014 | 260 | 0.090 |
Why?
|
| Cross-Sectional Studies | 4 | 2021 | 3658 | 0.090 |
Why?
|
| Calcium | 1 | 2016 | 1027 | 0.080 |
Why?
|
| California | 1 | 2010 | 123 | 0.080 |
Why?
|
| Kidney | 1 | 2017 | 1262 | 0.080 |
Why?
|
| Respiratory Mechanics | 1 | 2010 | 79 | 0.080 |
Why?
|
| Registries | 2 | 2019 | 1478 | 0.080 |
Why?
|
| Cardiovascular Agents | 1 | 2010 | 79 | 0.080 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2009 | 27 | 0.080 |
Why?
|
| Hospitals, Pediatric | 1 | 2014 | 777 | 0.080 |
Why?
|
| Reperfusion | 1 | 2009 | 25 | 0.080 |
Why?
|
| Pressure | 1 | 2009 | 123 | 0.070 |
Why?
|
| Hematologic Diseases | 1 | 2008 | 73 | 0.070 |
Why?
|
| Biomarkers | 2 | 2014 | 3149 | 0.070 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2009 | 200 | 0.070 |
Why?
|
| Quality Assurance, Health Care | 1 | 2008 | 196 | 0.070 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2010 | 351 | 0.060 |
Why?
|
| Incidence | 1 | 2014 | 3193 | 0.060 |
Why?
|
| Obesity | 1 | 2017 | 2328 | 0.060 |
Why?
|
| Methylprednisolone | 1 | 2005 | 90 | 0.060 |
Why?
|
| Linear Models | 2 | 2017 | 673 | 0.060 |
Why?
|
| Practice Guidelines as Topic | 1 | 2011 | 1229 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2014 | 1353 | 0.050 |
Why?
|
| Cannabinoids | 1 | 2024 | 32 | 0.050 |
Why?
|
| Cytokines | 1 | 2009 | 1317 | 0.050 |
Why?
|
| Glucocorticoids | 1 | 2005 | 354 | 0.050 |
Why?
|
| Troponin I | 1 | 2003 | 82 | 0.050 |
Why?
|
| Central Venous Pressure | 1 | 2022 | 26 | 0.050 |
Why?
|
| Prognosis | 1 | 2011 | 4697 | 0.050 |
Why?
|
| Phentolamine | 1 | 2021 | 16 | 0.050 |
Why?
|
| Morbidity | 2 | 2015 | 242 | 0.050 |
Why?
|
| Calcium Chloride | 1 | 2021 | 23 | 0.050 |
Why?
|
| Complement C3a | 1 | 2000 | 19 | 0.040 |
Why?
|
| Japan | 1 | 2020 | 171 | 0.040 |
Why?
|
| Double-Blind Method | 2 | 2003 | 1596 | 0.040 |
Why?
|
| Lactic Acid | 1 | 2020 | 144 | 0.040 |
Why?
|
| Medical Staff, Hospital | 1 | 2020 | 92 | 0.040 |
Why?
|
| Body Temperature | 1 | 2000 | 122 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2000 | 246 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2020 | 422 | 0.040 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 199 | 0.040 |
Why?
|
| Arterial Pressure | 1 | 2020 | 123 | 0.040 |
Why?
|
| Interleukin-6 | 1 | 2000 | 405 | 0.040 |
Why?
|
| Neutrophils | 1 | 2000 | 351 | 0.030 |
Why?
|
| Risk Adjustment | 1 | 2017 | 51 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2000 | 639 | 0.030 |
Why?
|
| Stroke Volume | 1 | 2020 | 490 | 0.030 |
Why?
|
| Furosemide | 1 | 2016 | 30 | 0.030 |
Why?
|
| Down Syndrome | 1 | 2019 | 200 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 2016 | 237 | 0.030 |
Why?
|
| Pulmonary Artery | 1 | 2020 | 445 | 0.030 |
Why?
|
| Birthing Centers | 1 | 2015 | 9 | 0.030 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2017 | 229 | 0.030 |
Why?
|
| Bradycardia | 1 | 2014 | 56 | 0.030 |
Why?
|
| Pregnancy | 2 | 2017 | 7395 | 0.030 |
Why?
|
| Advanced Cardiac Life Support | 1 | 2013 | 17 | 0.030 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 1146 | 0.020 |
Why?
|
| Gases | 1 | 2012 | 18 | 0.020 |
Why?
|
| Tertiary Care Centers | 1 | 2014 | 245 | 0.020 |
Why?
|
| Missouri | 1 | 2012 | 41 | 0.020 |
Why?
|
| Adult | 3 | 2020 | 30314 | 0.020 |
Why?
|
| Hypoglycemia | 1 | 2014 | 176 | 0.020 |
Why?
|
| Troponin | 1 | 2012 | 55 | 0.020 |
Why?
|
| Catheterization | 1 | 2014 | 232 | 0.020 |
Why?
|
| Radiography | 1 | 2014 | 748 | 0.020 |
Why?
|
| Administration, Oral | 1 | 2014 | 677 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2017 | 1645 | 0.020 |
Why?
|
| Patient Readmission | 1 | 2014 | 387 | 0.020 |
Why?
|
| Recurrence | 1 | 2014 | 1408 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2014 | 950 | 0.020 |
Why?
|
| Anticoagulants | 1 | 2014 | 559 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2012 | 1385 | 0.020 |
Why?
|
| Disease Progression | 1 | 2012 | 2110 | 0.010 |
Why?
|
| Health Care Surveys | 1 | 2005 | 279 | 0.010 |
Why?
|
| Young Adult | 1 | 2017 | 9635 | 0.010 |
Why?
|
| Perioperative Care | 1 | 2005 | 206 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2003 | 418 | 0.010 |
Why?
|
| Aged | 1 | 2020 | 20078 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2003 | 950 | 0.010 |
Why?
|
| Middle Aged | 1 | 2020 | 27402 | 0.010 |
Why?
|